Compare ONEOK Inc. Common Stock (OKE) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ONEOK Inc. Common Stock vs Oruka Therapeutics Inc. Common Stock — how do they compare? ONEOK Inc. Common Stock trades at $92.29 (market cap $58.87B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: ONEOK Inc. Common Stock is far larger — about 11.4× Oruka Therapeutics Inc. Common Stock's market cap, and ONEOK Inc. Common Stock pays a 4.58% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ONEOK Inc. Common Stock for 5 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| OKE | ORKA | |
|---|---|---|
Market Cap | $58.87B | $5.18B |
Volume | 2,504,054 | 490,798 |
Sector | Energy | Health |
52-Week High | $97.51 | $113.08 |
52-Week Low | $64.31 | $26.19 |
Typical Hold Time | 5 Days | 0 Days |
Enterprise Value | $91.73B | $4.31B |
Dividend Yield | 4.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ONEOK (OKE) trades at $93.38, up 1.48% with a bullish technical outlook and strong fundamental performance. The stock shows solid valuation metrics with P/E of 16.13 and P/S of 1.5, supported by $33.63B revenue and $3.39B net income in 2025. Recent acquisition of Brazos Midstream's assets for $4.425B expands Permian Basin presence, while quarterly dividends remain steady at $1.07 per share.
Outlook remains positive with analyst consensus target of $98.55 (5.5% upside) and no sell ratings. Key risks include integration of recent acquisition and commodity price exposure. Earnings beat expectations in 2 of last 3 quarters, with Q3 2026 results due October 27 providing next catalyst.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ONEOK Inc. Common Stock
ONEOK operates energy infrastructure for natural gas, natural gas liquids, and crude oil. Its assets include pipelines, processing facilities, storage, and related services.
Read more on OKE →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
